John Allard

About John Allard

Clinical Biomarker/ CDx Scientific lead supporting drug development of antibody-drug conjugate (ADC) therapeutics. I have proven ability to support effectively, multiple complex projects and clinical trials to completion in fast-paced and changing business environments and have taken over project responsibilities from other colleagues to maintain timelines / company goals as needed. I have excellent written and verbal communication skills and work very well in team environments with colleagues from many different backgrounds.

Experience

1. Director, Diagnostic Sciences, Global Companion Diagnostics

   Daiichi Sankyo US

   Apr 2022 — Present · Basking Ridge, NJ, US

   Lead CDx Scientist for implementation of CDx strategy for ENHERTU (DS8201a - HER2 ADC) development for NSCLC, GI cancer (Colorectal, Gastric, Gastroesophageal), Pan-Tumor and Rare disease cancer activities. Implement patient selection assays and monitor data generation in support of CDx analytical and clinical validation studies in collaboration with Diagnostics partner, and other supplemental studies to support development of Diagnostic devices under design control processes.

Education

• Stanford University

  Postdoctoral Fellowship

• Washington State University

  Ph.D.

• California State University, Long Beach

  B.S.

Skills

• In Vitro
• Drug Discovery
• Molecular Biology
• Scientific Sourcing
• Clinical Development
• Immunology
• Assay Development
• Biotechnology
• Drug Development
• Translational Research
• In Vivo
• Cell
• Project Management
• Biomarkers
• Elisa
• Genomics
• Biochemistry
• Inflammation
• Pharmacology
• Bioinformatics
• Biomarker Discovery
• Science
• Translational Medicine
• Lifesciences
• Virology